Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy

Assessment of minimal residual disease (MRD) is becoming a standard diagnostic tool for curable hematological malignancies such as chronic and acute myeloid leukemia. Multiple myeloma (MM) remains an incurable disease, as a major portion of patients even in complete response eventually relapse, sugg...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferla, Valeria, Antonini, Elena, Perini, Tommaso, Farina, Francesca, Masottini, Serena, Malato, Simona, Marktel, Sarah, Lupo Stanghellini, Maria Teresa, Tresoldi, Cristina, Ciceri, Fabio, Marcatti, Magda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426755/
https://www.ncbi.nlm.nih.gov/pubmed/36052251
http://dx.doi.org/10.3389/fonc.2022.932852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426755/
https://www.ncbi.nlm.nih.gov/pubmed/36052251
http://dx.doi.org/10.3389/fonc.2022.932852

Ejemplares similares